HomeNKGN • OTCMKTS
add
NKGen Biotech Inc
Previous close
$0.060
Year range
$0.00020 - $0.46
Market cap
7.84M USD
Avg Volume
4.90K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.67M | -38.77% |
Net income | 15.35M | 385.21% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.32M | 40.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.00K | -82.35% |
Total assets | 15.84M | -2.91% |
Total liabilities | 66.17M | -7.28% |
Total equity | -50.33M | — |
Shares outstanding | 130.60M | — |
Price to book | -0.06 | — |
Return on assets | -72.74% | — |
Return on capital | 80.06% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 15.35M | 385.21% |
Cash from operations | -2.80M | 30.59% |
Cash from investing | -52.00K | -248.57% |
Cash from financing | 2.65M | -33.97% |
Net change in cash | -206.00K | -2,675.00% |
Free cash flow | -1.39M | 81.04% |
About
Founded
2017
Headquarters
Website
Employees
26
